
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $236.6M | $387.9M | $585.9M | $777M | $963.6M | |
Revenue Growth (YoY) | 57.92% | 63.95% | 51.07% | 32.6% | 24.03% | |
Cost of Revenues | $75.5M | $137.3M | $202.4M | $229.7M | $257.5M | |
Gross Profit | $161.1M | $250.6M | $383.5M | $547.3M | $706.2M | |
Gross Profit Margin | 68.1% | 64.6% | 65.46% | 70.44% | 73.28% | |
R&D Expenses | $105.4M | $161.9M | $264M | $348.8M | $421.2M | |
Selling, General & Admin | $288.9M | $428.3M | $582.2M | $642.4M | $704.1M | |
Other Inc / (Exp) | $3.1M | -$7K | $16.4M | $37.2M | $84.5M | |
Operating Expenses | $394.3M | $590.2M | $846.2M | $991.2M | $1.1B | |
Operating Income | -$233.2M | -$339.6M | -$462.7M | -$443.9M | -$419.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$230M | -$339.6M | -$446.3M | -$406.7M | -$334.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$207K | $3.2M | $6.3M | $36.1M | $10.4M | |
Net Income to Company | -$229.8M | -$342.8M | -$452.6M | -$442.7M | -$345.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$229.8M | -$342.8M | -$452.6M | -$442.7M | -$345.1M | |
Basic EPS (Cont. Ops) | -$1.02 | -$1.82 | -$1.62 | -$1.47 | -$1.07 | |
Diluted EPS (Cont. Ops) | -$1.02 | -$1.82 | -$1.62 | -$1.47 | -$1.07 | |
Weighted Average Basic Share | $224.3M | $188.6M | $280.1M | $300.7M | $321.9M | |
Weighted Average Diluted Share | $224.3M | $188.6M | $280.1M | $300.7M | $321.9M | |
EBITDA | -$231.6M | -$336M | -$455.1M | -$430M | -$397.1M | |
EBIT | -$233.2M | -$339.6M | -$462.7M | -$443.9M | -$419.1M | |
Revenue (Reported) | $236.6M | $387.9M | $585.9M | $777M | $963.6M | |
Operating Income (Reported) | -$233.2M | -$339.6M | -$462.7M | -$443.9M | -$419.1M | |
Operating Income (Adjusted) | -$233.2M | -$339.6M | -$462.7M | -$443.9M | -$419.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $77M | $126.1M | $174.3M | $217.2M | $271.1M | |
Revenue Growth (YoY) | 51.32% | 63.76% | 38.18% | 24.63% | 24.8% | |
Cost of Revenues | $23.8M | $45.8M | $58.1M | $61.2M | $69.1M | |
Gross Profit | $53.2M | $80.4M | $116.2M | $156M | $202M | |
Gross Profit Margin | 69.05% | 63.71% | 66.64% | 71.82% | 74.51% | |
R&D Expenses | $24.3M | $57.7M | $84.9M | $97.6M | $116.8M | |
Selling, General & Admin | $74M | $134.2M | $164M | $169.8M | $186.4M | |
Other Inc / (Exp) | -$336K | -$816K | -$18.2M | $20.9M | $20.4M | |
Operating Expenses | $98.3M | $191.8M | $248.9M | $267.4M | $303.2M | |
Operating Income | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$44.6M | -$112.3M | -$150.9M | -$90.5M | -$80.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$110K | $689K | $1.6M | $2.5M | -$13.2M | |
Net Income to Company | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Basic EPS (Cont. Ops) | -$0.18 | -$0.41 | -$0.52 | -$0.30 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.18 | -$0.41 | -$0.52 | -$0.30 | -$0.20 | |
Weighted Average Basic Share | $252.4M | $272.9M | $291.9M | $314.2M | $335.8M | |
Weighted Average Diluted Share | $252.4M | $272.9M | $291.9M | $314.2M | $335.8M | |
EBITDA | -$44.4M | -$110.2M | -$129.6M | -$107M | -$94.6M | |
EBIT | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Revenue (Reported) | $77M | $126.1M | $174.3M | $217.2M | $271.1M | |
Operating Income (Reported) | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Operating Income (Adjusted) | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $262.7M | $437M | $634.1M | $819.9M | $1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $81.5M | $159.2M | $214.8M | $232.7M | $265.4M | |
Gross Profit | $181.2M | $277.7M | $419.3M | $587.1M | $752.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $110M | $195.3M | $291.3M | $361.4M | $440.5M | |
Selling, General & Admin | $316.2M | $488.4M | $612M | $648.3M | $720.7M | |
Other Inc / (Exp) | $3.1M | -$487K | -$965K | $76.3M | $84M | |
Operating Expenses | $426.1M | $683.7M | $903.2M | $1B | $1.2B | |
Operating Income | -$244.9M | -$406M | -$483.9M | -$422.6M | -$409M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$241.4M | -$407.3M | -$484.9M | -$346.3M | -$324.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$705K | $4M | $7.3M | $36.9M | -$5.3M | |
Net Income to Company | -$240.7M | -$411.3M | -$492.1M | -$383.2M | -$319.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$240.7M | -$411.3M | -$492.1M | -$383.2M | -$319.7M | |
Basic EPS (Cont. Ops) | -$1.05 | -$1.95 | -$1.72 | -$1.25 | -$0.98 | |
Diluted EPS (Cont. Ops) | -$1.05 | -$1.95 | -$1.72 | -$1.25 | -$0.98 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$242.8M | -$401.9M | -$474.4M | -$407.5M | -$384.6M | |
EBIT | -$244.9M | -$406M | -$483.9M | -$422.6M | -$409M | |
Revenue (Reported) | $262.7M | $437M | $634.1M | $819.9M | $1B | |
Operating Income (Reported) | -$244.9M | -$406M | -$483.9M | -$422.6M | -$409M | |
Operating Income (Adjusted) | -$244.9M | -$406M | -$483.9M | -$422.6M | -$409M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $77M | $126.1M | $174.3M | $217.2M | $271.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $23.8M | $45.8M | $58.1M | $61.2M | $69.1M | |
Gross Profit | $53.2M | $80.4M | $116.2M | $156M | $202M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $24.3M | $57.7M | $84.9M | $97.6M | $116.8M | |
Selling, General & Admin | $74M | $134.2M | $164M | $169.8M | $186.4M | |
Other Inc / (Exp) | -$336K | -$816K | -$18.2M | $20.9M | $20.4M | |
Operating Expenses | $98.3M | $191.8M | $248.9M | $267.4M | $303.2M | |
Operating Income | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$44.6M | -$112.3M | -$150.9M | -$90.5M | -$80.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$110K | $689K | $1.6M | $2.5M | -$13.2M | |
Net Income to Company | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Basic EPS (Cont. Ops) | -$0.18 | -$0.41 | -$0.52 | -$0.30 | -$0.20 | |
Diluted EPS (Cont. Ops) | -$0.18 | -$0.41 | -$0.52 | -$0.30 | -$0.20 | |
Weighted Average Basic Share | $252.4M | $272.9M | $291.9M | $314.2M | $335.8M | |
Weighted Average Diluted Share | $252.4M | $272.9M | $291.9M | $314.2M | $335.8M | |
EBITDA | -$44.4M | -$110.2M | -$129.6M | -$107M | -$94.6M | |
EBIT | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Revenue (Reported) | $77M | $126.1M | $174.3M | $217.2M | $271.1M | |
Operating Income (Reported) | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M | |
Operating Income (Adjusted) | -$45.1M | -$111.5M | -$132.7M | -$111.4M | -$101.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $36.8M | $1.4B | $435.8M | $349.8M | $386M | |
Short Term Investments | $251.8M | $640.1M | $1.5B | $1.6B | $1.5B | |
Accounts Receivable, Net | $106M | $105.2M | $126.9M | $165.8M | $183.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18.8M | -- | -- | -- | -- | |
Other Current Assets | -- | $44.9M | $57.2M | $77M | $79.2M | |
Total Current Assets | $427.7M | $2.2B | $2.2B | $2.3B | $2.4B | |
Property Plant And Equipment | $55M | $51.7M | $58.6M | $64.1M | $87.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $52M | $164.4M | |
Other Intangibles | -- | -- | -- | $3.5M | $7.9M | |
Other Long-Term Assets | $10.2M | $13.8M | $19.8M | $13.8M | $12.3M | |
Total Assets | $526.1M | $2.3B | $2.3B | $2.5B | $2.7B | |
Accounts Payable | $1.6M | $7.6M | $21.4M | $6.7M | $7.5M | |
Accrued Expenses | $17.4M | $31.2M | $34.9M | $30.9M | $40.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $10.5M | $9.2M | $7.4M | $7.9M | $8.7M | |
Other Current Liabilities | $10.4M | $12.2M | $17M | $11.1M | $21.6M | |
Total Current Liabilities | $193.8M | $348.2M | $424.3M | $487M | $589.2M | |
Long-Term Debt | -- | $1.1B | $1.1B | $1.1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $832.4M | $1.5B | $1.6B | $1.7B | $1.7B | |
Common Stock | $1K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | $228K | -$830K | -$9.5M | $1.3M | -$2.6M | |
Common Equity | -$306.2M | $850.3M | $769.5M | $810.4M | $961.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$306.2M | $850.3M | $769.5M | $810.4M | $961.2M | |
Total Liabilities and Equity | $526.1M | $2.3B | $2.3B | $2.5B | $2.7B | |
Cash and Short Terms | $288.5M | $2B | $1.9B | $1.9B | $1.9B | |
Total Debt | -- | $1.1B | $1.1B | $1.1B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $44.1M | $1B | $343.5M | $336.4M | $278.6M | |
Short Term Investments | $236M | $943M | $1.5B | $1.6B | $1.6B | |
Accounts Receivable, Net | $99.8M | $124.5M | $115.3M | $199.8M | $150.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $14.2M | $51.7M | -- | -- | -- | |
Other Current Assets | $663K | -- | $58.7M | $76.1M | $82.3M | |
Total Current Assets | $417.2M | $2.2B | $2.1B | $2.2B | $2.3B | |
Property Plant And Equipment | $52.7M | $53.3M | $48.1M | $70.8M | $89.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | $164.4M | |
Other Intangibles | -- | -- | -- | $55M | $7.5M | |
Other Long-Term Assets | $12.8M | $15M | $16.6M | $14.2M | $25.3M | |
Total Assets | $519M | $2.3B | $2.3B | $2.4B | $2.7B | |
Accounts Payable | $2.3M | $8.2M | $10.4M | $1.9M | $6M | |
Accrued Expenses | $18.6M | $28.7M | $27M | $26M | $32.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $10.5M | $8.5M | $7.3M | $10.1M | $9.1M | |
Other Current Liabilities | $14.4M | $16.2M | $14M | $15M | $19.1M | |
Total Current Liabilities | $211.7M | $330.7M | $401.2M | $439.2M | $529.9M | |
Long-Term Debt | -- | $1.1B | $1.1B | $1.1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $849M | $1.5B | $1.5B | $1.6B | $1.7B | |
Common Stock | $1K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | $43K | -$5.5M | -$4.5M | -$2.3M | $2.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$330.1M | $836.1M | $744.9M | $845.2M | $1B | |
Total Liabilities and Equity | $519M | $2.3B | $2.3B | $2.4B | $2.7B | |
Cash and Short Terms | $280.1M | $2B | $1.8B | $1.9B | $1.9B | |
Total Debt | -- | $1.1B | $1.1B | $1.1B | $1.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$229.8M | -$342.8M | -$452.6M | -$442.7M | -$345.1M | |
Depreciation & Amoritzation | $1.6M | $3.6M | $7.6M | $13.9M | $22.1M | |
Stock-Based Compensation | $143.3M | $155.6M | $277.7M | $349.8M | $395.7M | |
Change in Accounts Receivable | -$41.6M | -$32.5M | -$42.1M | -$53.6M | -$86.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$82.1M | -$105.1M | -$157.3M | -$103.7M | $33.5M | |
Capital Expenditures | $4.7M | $8.9M | $14.5M | $20.7M | $24M | |
Cash Acquisitions | -- | -- | -- | -$55.8M | -$115.5M | |
Cash From Investing | -$176.9M | -$400.6M | -$865.8M | -$84.9M | -$75M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $1.1B | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$786K | -- | -- | |
Repurchase of Common Stock | -- | -$482K | -$789K | -$255K | -- | |
Other Financing Activities | -$111K | -$94.1M | -$786K | -- | -- | |
Cash From Financing | $276.8M | $1.8B | $82.2M | $102.4M | $79.8M | |
Beginning Cash (CF) | $20M | $37.8M | $1.4B | $435.8M | $349.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $17.8M | $1.3B | -$940.9M | -$86.1M | $38.3M | |
Ending Cash (CF) | $37.8M | $1.4B | $435.8M | $349.8M | $386M | |
Levered Free Cash Flow | -$86.7M | -$114M | -$171.8M | -$124.3M | $9.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Depreciation & Amoritzation | $787K | $1.3M | $3.1M | $4.3M | $6.6M | |
Stock-Based Compensation | $13.4M | $57.4M | $79.3M | $95.3M | $92.6M | |
Change in Accounts Receivable | $5.7M | $12.8M | $8.1M | $29.4M | $15.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$20M | -$55M | -$77.8M | -$26M | -$26.8M | |
Capital Expenditures | $1.2M | $3.4M | $5.1M | $5.7M | $6.2M | |
Cash Acquisitions | -- | -- | -$45.8M | -- | -- | |
Cash From Investing | $13.8M | -$311.7M | -$52.5M | -$16.8M | -$112M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$153K | -$786K | -- | -- | -- | |
Cash From Financing | $13.5M | $38.5M | $37.7M | $30M | $30.8M | |
Beginning Cash (CF) | $37.8M | $1.4B | $435.8M | $349.8M | $386M | |
Foreign Exchange Rate Adjustment | -$8K | -$46K | $205K | -$673K | $537K | |
Additions / Reductions | $7.3M | -$328.3M | -$92.5M | -$12.7M | -$108M | |
Ending Cash (CF) | $45.1M | $1B | $343.5M | $336.4M | $278.6M | |
Levered Free Cash Flow | -$21.2M | -$58.4M | -$82.9M | -$31.7M | -$33M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$240.7M | -$411.3M | -$492.1M | -$383.2M | -$319.7M | |
Depreciation & Amoritzation | $2.1M | $4.1M | $9.5M | $15.1M | $24.4M | |
Stock-Based Compensation | $150.2M | $199.6M | $299.6M | $365.9M | $392.9M | |
Change in Accounts Receivable | -$26.8M | -$25.5M | -$46.8M | -$32.3M | -$100.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$71M | -$140.1M | -$180.1M | -$51.8M | $32.7M | |
Capital Expenditures | $4.6M | $11.1M | $16.2M | $21.3M | $24.5M | |
Cash Acquisitions | -- | -- | -$45.8M | -$10M | -$115.5M | |
Cash From Investing | -$148M | -$726.2M | -$606.6M | -$49.1M | -$170.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$94.7M | -- | -- | -- | |
Cash From Financing | $63.2M | $1.9B | $81.5M | $94.6M | $80.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$155.8M | $1B | -$705.1M | -$6.3M | -$57M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$75.6M | -$151.2M | -$196.2M | -$73.1M | $8.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$44.5M | -$113M | -$152.6M | -$93M | -$67.6M | |
Depreciation & Amoritzation | $787K | $1.3M | $3.1M | $4.3M | $6.6M | |
Stock-Based Compensation | $13.4M | $57.4M | $79.3M | $95.3M | $92.6M | |
Change in Accounts Receivable | $5.7M | $12.8M | $8.1M | $29.4M | $15.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$20M | -$55M | -$77.8M | -$26M | -$26.8M | |
Capital Expenditures | $1.2M | $3.4M | $5.1M | $5.7M | $6.2M | |
Cash Acquisitions | -- | -- | -$45.8M | -- | -- | |
Cash From Investing | $13.8M | -$311.7M | -$52.5M | -$16.8M | -$112M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$153K | -$786K | -- | -- | -- | |
Cash From Financing | $13.5M | $38.5M | $37.7M | $30M | $30.8M | |
Beginning Cash (CF) | $37.8M | $1.4B | $435.8M | $349.8M | $386M | |
Foreign Exchange Rate Adjustment | -$8K | -$46K | $205K | -$673K | $537K | |
Additions / Reductions | $7.3M | -$328.3M | -$92.5M | -$12.7M | -$108M | |
Ending Cash (CF) | $45.1M | $1B | $343.5M | $336.4M | $278.6M | |
Levered Free Cash Flow | -$21.2M | -$58.4M | -$82.9M | -$31.7M | -$33M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.